<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04711317</url>
  </required_header>
  <id_info>
    <org_study_id>PRIOROB</org_study_id>
    <nct_id>NCT04711317</nct_id>
  </id_info>
  <brief_title>Pre-oxygenation With High-flow Nasal Cannula in Caesarian Section Under General Anesthesia</brief_title>
  <acronym>PRIOROB</acronym>
  <official_title>Pre-oxygenation With High-flow Nasal Cannula in Pregnant Women Undergoing Caesarian Section Under General Anesthesia - a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Danderyds Hospital, Stockholm, Sweden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Stockholm South General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Karlstad Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Karolinska University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators and other groups have demonstrated that high-flow nasal oxygen used during&#xD;
      preoxygenation for emergency surgery is at least equally effective as preoxygenation compared&#xD;
      to standard tight fitting mask. The investigators also have data from a recent study that&#xD;
      indicates that high-flow nasal oxygen might decrease the risk of clinically relevant&#xD;
      desaturation below 93% of arterial oxygen saturation.&#xD;
&#xD;
      The studies investigating the concept of high-flow nasal oxygen has up to this date excluded&#xD;
      pregnant women. Pregnant woman is a patient group with known difficulties to maintain&#xD;
      adequate saturation levels during apnoea. Due to smaller functional residual capacity their&#xD;
      oxygen stores after preoxygenation are smaller compared to patients with a normal body mass&#xD;
      index. The pregnant woman also have a higher oxygen demand and metabolism due to the growing&#xD;
      placenta and the fetus. Pregnant women are therefore a patient group where a method that&#xD;
      could prolong time until desaturation would be even more valuable and potentially could save&#xD;
      lives.&#xD;
&#xD;
      Based on the above, the investigators now aim to conduct a clinical pilot study, where&#xD;
      pregnant women undergoing caesarian section under general anesthesia are pre and&#xD;
      perioxygenated with high-flow nasal oxygen. Data from that group will be compared with&#xD;
      patients preoxygenated in a traditional manner with tight facemask. This study is done to&#xD;
      evaluate an established technique on a patient category that in theory could gain a lot from&#xD;
      it.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">March 3, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>One intervention group that is compared to a control group that is standard treatment.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of lowest median Peripheral arterial oxygen saturation between intervention and control</measure>
    <time_frame>Up to 1 minute after intubation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparison of Endtidal concentration of oxygen after intubation between intervention and control</measure>
    <time_frame>The first breaths after intubation eg. within 20 seconds of intubation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of Endtidal carbondioxide concentration after intubation between intervention and control</measure>
    <time_frame>The first breaths after intubation eg. within 20 seconds of intubation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of Number of patients with regurgitation of gastric contents between intervention and control</measure>
    <time_frame>During intubation eg up to 0 seconds after intubation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of number of patients desaturating below 93% between intervention and control</measure>
    <time_frame>Up to 1 minute after intubation</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Pregnancy Related</condition>
  <condition>Anesthesia</condition>
  <condition>Oxygen Deficiency</condition>
  <condition>Cesarean Section Complications</condition>
  <arm_group>
    <arm_group_label>Preoxygenation with nasal high flow oxygen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Preoxygenation with nasal high flow oxygen</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard preoxygenation according to hospital protocol with tight fitting facemask</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nasal high flow oxygen</intervention_name>
    <description>Pregnant women scheduled for cesarian section in general anaesthesia will be preoxygenated using nasal high flow oxygen</description>
    <arm_group_label>Preoxygenation with nasal high flow oxygen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Adult, &gt;18 years old&#xD;
&#xD;
          2. Caesarian section under general anesthesia.&#xD;
&#xD;
          3. Pregnant in week 30 or later&#xD;
&#xD;
          4. Capable of understanding the study information and signing the written consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. BMI &gt;45&#xD;
&#xD;
          2. Dependency on non-invasive ventilation to maintain oxygen saturation&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Malin Jonsson Fagerlund</last_name>
    <role>Principal Investigator</role>
    <affiliation>Karolinska University Hospital and Karolinska Insitutet</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Karlstads Centralsjukhus</name>
      <address>
        <city>Karlstad</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Danderyds Hospital</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Karolinska University Hospital, Solna</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SÃ¶dersjukhuset</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>December 9, 2020</study_first_submitted>
  <study_first_submitted_qc>January 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 15, 2021</study_first_posted>
  <last_update_submitted>June 4, 2021</last_update_submitted>
  <last_update_submitted_qc>June 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska University Hospital</investigator_affiliation>
    <investigator_full_name>Malin Jonsson Fagerlund</investigator_full_name>
    <investigator_title>Senior Consultant, Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Preoxygenation</keyword>
  <keyword>Perioxygenation</keyword>
  <keyword>Nasal high flow oxygen</keyword>
  <keyword>Cesarian sectio</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoxia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

